Heparanase expression correlates with malignant potential in human colon cancer - PubMed (original) (raw)

. 2005 Apr;131(4):229-37.

doi: 10.1007/s00432-004-0644-x. Epub 2004 Dec 30.

Y Naomoto, T Ohkawa, M Takaoka, R Ono, T Murata, M Gunduz, Y Shirakawa, T Yamatsuji, M Haisa, J Matsuoka, H Tsujigiwa, H Nagatsuka, M Nakajima, N Tanaka

Affiliations

• PMID: 15625607
• DOI: 10.1007/s00432-004-0644-x

Heparanase expression correlates with malignant potential in human colon cancer

T Nobuhisa et al. J Cancer Res Clin Oncol. 2005 Apr.

Abstract

Purpose: Heparanase cleaves carbohydrate chains of heparan sulphate proteoglycans and is an important component of the extracellular matrix. This study was designed to determine the relation between heparanase expression and prognosis of patients with colon cancer.

Methods: The study included 54 patients (35 males and 19 females) who underwent colorectal resection for colorectal cancer between January 1992 and December 1994. Expression of heparanase protein and mRNA were determined and correlated with various clinicopathological parameters. In vitro studies were also performed to examine tumor invasion and to test the effects of heparanase inhibition, and in vivo studies were performed to examine tumor metastasis and prognosis.

Results: Heparanase expression was detected in the invasion front of the tumor in 37 of 54 (69%) colon cancer samples, whereas 17 of 54 (31%) tumors were negative. Expression of heparanase was significantly more frequent in tumors of higher TNM stage (P=0.0481), higher Dukes stage (P=0.0411), higher vascular infiltration (P=0.0146), and higher lymph vessel infiltration (P=0.0010). Heparanase expression in colon cancers correlated significantly with poor survival (P=0.0361). Heparanase-transfected colon cancer cells exhibited significant invasion compared with control-transfected colon cancer cells (P=0.001), and the peritoneal dissemination model also showed the malignant potential of heparanase-transfected cells, as assayed by number of nodules (P=0.017) and survival (P=0.0062). Inhibition of heparanase significantly reduced the invasive capacity of cancer cells (P=0.003).

Conclusions: Heparanase is a marker for poor prognosis of patients with colon cancer and could be a suitable target for antitumor therapy in colon cancer.

PubMed Disclaimer

Similar articles

• Heparanase expression correlates with invasion and poor prognosis in gastric cancers.
  Takaoka M, Naomoto Y, Ohkawa T, Uetsuka H, Shirakawa Y, Uno F, Fujiwara T, Gunduz M, Nagatsuka H, Nakajima M, Tanaka N, Haisa M. Takaoka M, et al. Lab Invest. 2003 May;83(5):613-22. doi: 10.1097/01.lab.0000067482.84946.bd. Lab Invest. 2003. PMID: 12746471
• Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
  Beckhove P, Helmke BM, Ziouta Y, Bucur M, Dörner W, Mogler C, Dyckhoff G, Herold-Mende C. Beckhove P, et al. Clin Cancer Res. 2005 Apr 15;11(8):2899-906. doi: 10.1158/1078-0432.CCR-04-0664. Clin Cancer Res. 2005. PMID: 15837740
• [Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29].
  Liu Y, Ding YQ, Xin XY, Han LF, Liang L. Liu Y, et al. Ai Zheng. 2005 Dec;24(12):1427-30. Ai Zheng. 2005. PMID: 16351786 Chinese.
• The role of heparanase in gastrointestinal cancer (Review).
  Naomoto Y, Takaoka M, Okawa T, Nobuhisa T, Gunduz M, Tanaka N. Naomoto Y, et al. Oncol Rep. 2005 Jul;14(1):3-8. Oncol Rep. 2005. PMID: 15944760 Review.
• Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
  Vlodavsky I, Elkin M, Pappo O, Aingorn H, Atzmon R, Ishai-Michaeli R, Aviv A, Pecker I, Friedmann Y. Vlodavsky I, et al. Isr Med Assoc J. 2000 Jul;2 Suppl:37-45. Isr Med Assoc J. 2000. PMID: 10909416 Review.

Cited by

• Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinoma.
  Ralph S, Brenchley PE, Summers A, Rosa DD, Swindell R, Jayson GC. Ralph S, et al. Cancer Sci. 2007 Jun;98(6):844-9. doi: 10.1111/j.1349-7006.2007.00461.x. Epub 2007 Apr 5. Cancer Sci. 2007. PMID: 17419711 Free PMC article.
• Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.
  Yan L, Yan K, Kun W, Xu L, Ma Q, Tang Y, Jiao W, Gu G, Fan Y, Xu Z. Yan L, et al. Tumour Biol. 2013 Feb;34(1):215-21. doi: 10.1007/s13277-012-0531-z. Epub 2012 Oct 12. Tumour Biol. 2013. PMID: 23065570
• The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.
  He YQ, Sutcliffe EL, Bunting KL, Li J, Goodall KJ, Poon IK, Hulett MD, Freeman C, Zafar A, McInnes RL, Taya T, Parish CR, Rao S. He YQ, et al. Transcription. 2012 May-Jun;3(3):130-45. doi: 10.4161/trns.19998. Transcription. 2012. PMID: 22771948 Free PMC article.
• Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.
  Liu M, Xu X, Peng K, Hou P, Yuan Y, Li S, Sun X, Shi Z, Zhang J, Dong Y, Liu Q, Ai L, Liang L, Gan L, Huang Q, Yu Y, Liu T. Liu M, et al. Oncogenesis. 2022 Sep 21;11(1):58. doi: 10.1038/s41389-022-00428-0. Oncogenesis. 2022. PMID: 36130926 Free PMC article.
• Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer.
  Xie ZJ, Liu Y, Jia LM, He YC. Xie ZJ, et al. World J Gastroenterol. 2008 Jun 28;14(24):3812-8. doi: 10.3748/wjg.14.3812. World J Gastroenterol. 2008. PMID: 18609704 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer